Cargando...
Interim treatment: Bridging delays to opioid treatment access
OBJECTIVE: Despite the undisputed effectiveness of agonist maintenance for opioid dependence, individuals can remain on waitlists for months, during which they are at significant risk for morbidity and mortality. To mitigate these risks, the Food and Drug Administration in 1993 approved interim trea...
Guardado en:
| Publicado en: | Prev Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4592374/ https://ncbi.nlm.nih.gov/pubmed/25937593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ypmed.2015.04.017 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|